AccurKardia Inc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
AccurKardia Inc - overview
Established
2019
Location
New York, NY, US
Primary Industry
Software
About
Founded in 2019 by its CEO, Juan C. Jimenez, CPO, Mohamed Sadeq Ali, and chief scientist, Naveen Srinivas, and based in New York, US, AccurKardia Inc. , operates as a software company that provides automated ECG interpretation software that helps in cardiac monitoring. In June 2023, AccurKardia raised USD 2.
7 million in seed funding from the Popular Impact Fund, with participation from other unspecified investors. The company offers clinical-grade ECG interpretation software used for cardiac-care and monitoring through data collection and analysis from Holters, event recorders, and other devices. The company’s product portfolio includes AccurECG, a cloud-based web application, AccurAPI, and AccurBeat, an iOS app for the Apple Watch ECG, along with independent clinical and scientific research solutions. The company plans to use the June 2023 funding to introduce its technology to the market and collaborate with leading cardiology monitoring service providers.
Current Investors
Popular Impact Fund
Primary Industry
Software
Sub Industries
Medical Software
Website
www.accurkardia.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.